Celldex third quarter net loss increases to $11.8 million

[News]

Celldex Therapeutics, Inc. today reported financial results for the third quarter and nine months ended September 30, 2011. Celldex reported a net loss of $11.8 million, or $0.27 per share, for the third quarter of 2011 compared to a net loss of $9.1 million, or $0.28 per share, for the third quarter of 2010.

More... (http://www.news-medical.net/news/20111102/Celldex-third-quarter-net-loss-increases-to-24118-million.aspx)